Table 6.
Joanna Brigg’s institute critical appraisal checklist for case reports.
| Author’s Name | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Total | % | ROB |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ahmed et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Ahmed et al. | No | No | Yes | Yes | Yes | Yes | No | Yes | 5 | 63% | Moderate risk |
| Ahn et al. | No | No | Yes | Yes | Yes | Yes | Yes | Yes | 6 | 75% | Low risk |
| Albsheer et al. | No | Yes | Yes | Yes | No | No | No | Yes | 4 | 50% | Moderate risk |
| Aljamea et al. | UC | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Al-Quliti et.al | No | Yes | Yes | Yes | Yes | No | No | Yes | 5 | 63% | Moderate risk |
| Ancau et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Asaduzzaman et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Autjimanon et al. | No | Yes | Yes | Yes | Yes | Yes | UC | Yes | 6 | 75% | Low risk |
| Bastide et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Cao et al. | No | Yes | Yes | Yes | Yes | Yes | UC | Yes | 6 | 75% | Low risk |
| Ebadi et al. | No | Yes | Yes | No | No | No | No | Yes | 3 | 38% | High risk |
| Escolà et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Etemadifaret et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Fan et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Fernandes et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Flannery et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Gao et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Garibashvili et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Gogu et al. | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 | 100% | Low risk |
| Grossi et al. | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 | 100% | Low risk |
| Huang et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Jarius et al. | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | 7 | 88% | Low risk |
| K. Kania et al. | No | Yes | Yes | Yes | No | Yes | UC | Yes | 5 | 63% | Moderate risk |
| Kobayashi et al. | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | 7 | 88% | Low risk |
| Kobayashi et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Kwon et al. | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 | 100% | Low risk |
| Lagioia et al. | No | Yes | No | No | No | No | No | No | 1 | 13% | High risk |
| Lazaro et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Li et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Mörz et al. | No | Yes | Yes | No | No | No | No | Yes | 3 | 38% | High risk |
| Moslemi et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Nagaratnam et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Naz et al. | No | Yes | Yes | Yes | Yes | Yes | UC | Yes | 6 | 75% | Low risk |
| Permezel et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Rastogi et al. | No | Yes | Yes | Yes | Yes | Yes | UC | Yes | 6 | 75% | Low risk |
| Rinaldi et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |
| Saad et al. | No | No | Yes | No | Yes | Yes | Yes | Yes | 5 | 63% | Moderate risk |
| Sawczyńska et al. | No | No | Yes | Yes | Yes | Yes | Yes | Yes | 6 | 75% | Low risk |
| Senda et al. | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | 8 | 100% | Low risk |
| Shin HR et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 | 100% | Low risk |
| Shyu et al. | No | No | Yes | Yes | Yes | Yes | No | Yes | 5 | 63% | Moderate risk |
| Sluyts et al. | No | Yes | Yes | Yes | No | No | No | Yes | 4 | 50% | Moderate risk |
| Takata et al. | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 | 100% | Low risk |
| Torrealba-Acosta et al. | No | Yes | Yes | Yes | No | Yes | UC | Yes | 5 | 63% | Moderate risk |
| Vences et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Vogrig et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Walter et al. | No | No | Yes | Yes | Yes | Yes | NA | Yes | 5 | 63% | Moderate risk |
| Werner et al. | No | Yes | Yes | Yes | Yes | Yes | UC | Yes | 6 | 75% | Low risk |
| Yazdanpanah et al. | Yes | Yes | Yes | Yes | No | Yes | No | Yes | 6 | 75% | Low risk |
| Zlotnik et al. | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 7 | 88% | Low risk |
| Zuhorn et al. | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 6 | 75% | Low risk |